Tarsons Products Ltd - 543399 - Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that based on rating assessment undertaken by CARE Ratings Limited, the credit rating of the Company have been revised. Tarsons Products Ltd - 543399 - Audio Recording Of Investors Conference Call
In continuation to our letter dated 20th October, 2022 regarding intimation of Investors/Analyst conference call on the Unaudited Financial Results of the Company for the second quarter and half year ended 30th September, 2022, we would like to inform you that the audio recording of the said call has been uploaded on the Company's website. This can be accessed via the following link. Link: https://tarsons.com/wp-content/uploads/2022/11/Tarsons-Products-Limited-Q2-FY23-Earnings-Call-Audio.mp3 Tarsons Products Ltd - 543399 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of newspaper publication dated 6th November, 2022 of Unaudited Financial Results of the Company for the second quarter and half-year ended 30th September, 2022 as approved at the meeting of the Board of Directors of the Company held on Saturday, 5th November, 2022 in the following newspapers: 1. Financial Express, English National Publication 2. Aajkal, Bengali Kolkata Publication Q2FY23 Quarterly Result Announced for Tarsons Products Ltd.
Plastic Product manufacturer Tarsons Products announced Q2FY23 results: Revenue for Q2FY23 stood at Rs 71.2 crore as compared to Rs 76.0 crore in Q2FY22 The dip in the revenue was on account of the high share of covid related revenues during H1FY22 EBIDTA for Q2FY23 stood at Rs 32.7 crore as compared to Rs 38.5 crore in Q2FY22 EBIDTA margins have been impacted on account of manpower costs for upcoming facility & Marketing & Branding expenses in the exports markets to fuel future growth engines Commenting on the Q2FY23 performance of the company, Rohan Sehgal said: “Our revenues for Q2FY23 were down by 6% on a YoY basis and up by 4% on a QoQ basis. If we compare on a like-to-like basis, i.e. negating the high base of covid related revenues in H1FY22, our conventional business has shown substantial growth. In addition, our product portfolio and a wide network of distributors across India. We are confident of sustaining our growth in the domestic conventional business. Our export revenues have grown by 11% & 12% for Q2 & H1FY23 respectively. With expanding product portfolio and the Brand & Trust, Tarsons has developed over the last four decades. We are confident of expanding our footprints in the global markets. Our capacity expansion is on track and the commissioning of the upcoming facility is expected to be in H1FY24. We are confident of ramping up this facility in a short span because Tarsons as a brand has grown in popularity for quality products and timely delivery. Our strategy is to be present in all business segments of the life science industry, gain a significant share of the Indian market, and strengthen our presence in the export markets.” Result PDF Tarsons Products Ltd - 543399 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we are enclosing herewith an Investors Presentation on the Operational & Financial Highlights for the quarter ended 30th September, 2022. The Presentation will also be uploaded on the Company's website at www.tarsons.com. Tarsons Products Ltd - 543399 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Pursuant to the aforesaid Regulations, please find enclosed herewith the Monitoring Agency Report in respect of utilization of proceeds of the Initial Public Offer of the Company for the quarter ended 30th September, 2022, as issued by Axis Bank Limited, Monitoring Agency. Tarsons Products Ltd - 543399 - Statement Of Deviation Or Variation In The Use Of Proceeds Of Initial Public Offer Of Tarsons Products Limited For The Quarter Ended 30Th September, 2022
Pursuant to the Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular CIR/CFD/CMD1/162/2019 dated December 24, 2019, we request you to note that there are no deviation(s) or variation(s) in respect of utilization of proceeds of Initial Public Offer of the Company for the quarter ended 30th September, 2022, as mentioned in the object clause of the offer letter of the issue. In this regard, please find enclosed herewith the said statement. The aforesaid statement will also be available on the Company's website at www.tarsons.com. Tarsons Products Ltd - 543399 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday, 5Th November, 2022
In continuation to our letter dated 18th October, 2022 and pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company at their meeting held today i.e., on Saturday, 5th November, 2022, which commenced at 03:00 P.M. and concluded at 3:42 P.M., have inter alia, considered, approved and taken on record the following: 1. Unaudited Financial Results of the Company along with Limited Review Report as issued by the Statutory Auditors of the Company for the second quarter and half year ended 30th September, 2022. Tarsons Products Ltd - 543399 - Outcome Of The Board Meeting Held On Saturday, 5Th November, 2022
In continuation to our letter dated 18th October, 2022 and pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company at their meeting held today i.e., on Saturday, 5th November, 2022, which commenced at 03:00 P.M. and concluded at 4:00 P.M., have inter alia, considered, approved and taken on record the following: 1. Unaudited Financial Results of the Company along with Limited Review Report as issued by the Statutory Auditors of the Company for the second quarter and half year ended 30th September, 2022. Tarsons Products Ltd - 543399 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Investor/Analyst meet of the Company will be held on Monday, 7th November, 2022 at 12:00 Noon (IST). The details are enclosed herewith and this information will also be available on the website of the Company at www.tarsons.com. Kindly note that changes may happen due to exigencies on the part of Participants/Company. This is for your information and records.